Evaluating the care cascade after antiretroviral therapy initiation in Latin America.

Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
复制标题

DOI:
10.1177/0956462417714094
复制
发表时间:
2018-01
影响因子:
1.4
通讯作者:
Caribbean, Central and South America network for HIV epidemiology (CCASAnet)
Caribbean, Central and South America network for HIV epidemiology (CCASAnet)
中科院分区:
医学4区
文献类型:
--
作者:
Wolff MJ;Cortes CP;Mejìa FA;Padgett D;Belaunzarán-Zamudio P;Grinsztejn B;Giganti MJ;McGowan CC;Rebeiro PF;Caribbean, Central and South America network for HIV epidemiology (CCASAnet)

文献摘要

参考文献

被引文献

相似文献

必须优先考虑在低收入和中等收入国家加快抗逆转录病毒治疗(ART)的实施、提高保留率并实现病毒抑制。我们评估了拉丁美洲大型队列中这些里程碑的趋势和差异。对 2003 年至 2014 年在加勒比海、中美洲和南美洲 HIV 流行病学站点开始 ART (ARTstart) 的成年人进行护理级联结果评估:ARTstart 时 CD4 细胞计数 >200 个细胞/mm3;保留(ARTstart 后一年≥1 次就诊);病毒抑制(ART开始后一年≥1 HIV-1 RNA <200拷贝/ml)。修正泊松回归提供了按年龄、性别和 HIV 传播风险调整后的患病率,并考虑了 ARTstart 的地点和年份。随着时间的推移,实现 ARTstart 和抑制的比例有所提高 (p < 0.05)。年龄较大与更好的保留和病毒抑制相关,但在 CD4 细胞计数 >200 个细胞/mm3 时启动 ART 则不然。 ARTstart 时,女性和男男性行为者 (MSM) 的 CD4 细胞计数 >200 个细胞/mm3 的可能性更大。注射吸毒者 (IDU) 保留的可能性较小,而 MSM 则更有可能实现病毒抑制(所有 p <0.05)。尽管十年来该队列的这些结果有所改善,但仍存在显着差异,这对年轻患者、男性和注射吸毒者不利。这些差距表明在提供早期诊断方面不断取得进展,而 ARTstart 仍然至关重要。
Accelerating antiretroviral therapy (ART) administration, improving retention, and achieving viral suppression in low- and middle-income countries must be prioritized. We evaluated trends and disparities in these milestones in a large Latin American cohort. Adults starting ART (ARTstart) from 2003 to 2014 at Caribbean, Central, and South America network for HIV epidemiology sites were assessed for care cascade outcomes: CD4 cell count >200 cells/mm3 at ARTstart; retention (≥1 visit at one year after ARTstart); viral suppression (≥1 HIV-1 RNA <200 copies/ml at one year after ARTstart). Modified Poisson regression provided adjusted prevalence ratios by age, gender, and HIV transmission risk, accounting for site and year of ARTstart. Proportions achieving ARTstart and suppression improved over time (p < 0.05). Older age was associated with better retention and viral suppression, but not ARTstart at CD4 cell count >200 cells/mm3. Females and men who have sex with men (MSM) were more likely to have CD4 cell count >200 cells/mm3 at ARTstart. Injection drug users (IDUs) were less likely to be retained while MSM were more likely to achieve viral suppression (all p <0.05). Despite improvements in these outcomes over the course of a decade in this cohort, significant disparities existed, disadvantaging younger patients, men, and IDUs. These gaps indicate continued progress in providing early diagnosis and ARTstart remain critical.
DOI: 10.1136/sextrans-2012-050658
发表时间: 2012-12
影响因子: 3.6
作者:
Yiannoutsos CT;Johnson LF;Boulle A;Musick BS;Gsponer T;Balestre E;Law M;Shepherd BE;Egger M;International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
通讯作者: International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
DOI: 10.1016/s0140-6736(10)60829-x
发表时间: 2010-07-31
期刊: Lancet (London, England)
影响因子: --
作者:
Altice FL;Kamarulzaman A;Soriano VV;Schechter M;Friedland GH
通讯作者: Friedland GH
DOI: 10.1097/qai.0b013e3181d73e1b
发表时间: 2010-08-01
影响因子: 3.6
作者:
Tassie, Jean-Michel;Baijal, Parijat;Souteyrand, Yves
通讯作者: Souteyrand, Yves
DOI: 10.1097/qai.0000000000000489
发表时间: 2015-04-01
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者:
Yehia BR;Rebeiro P;Althoff KN;Agwu AL;Horberg MA;Samji H;Napravnik S;Mayer K;Tedaldi E;Silverberg MJ;Thorne JE;Burchell AN;Rourke SB;Rachlis A;Mayor A;Gill MJ;Zinski A;Ohl M;Anastos K;Abraham AG;Kitahata MM;Moore RD;Gebo KA;North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
通讯作者: North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
DOI: 10.7448/ias.19.1.20636
发表时间: 2016-04-08
影响因子: 6
作者:
Rebeiro, Peter F.;Cesar, Carina;Cahn, Pedro
通讯作者: Cahn, Pedro